Gastroenteropancreatic neuroendocrine tumor registry study in China
Abstract. Objectives:. The aim of this multicenter, prospective, registry study was to summarize the epidemiology of Chinese patients with locally advanced and end-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as the diagnostic methods and treatment strategies used for these...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2018-12-01
|
| Series: | Journal of Pancreatology |
| Online Access: | http://journals.lww.com/10.1097/JP9.0000000000000005 |
| _version_ | 1819292297241559040 |
|---|---|
| author | Lin Cong, MD Wenming Wu, MD Wenhui Lou, MD Jinwan Wang, MD Feng Gu, MD Jiaming Qian, MD Jianming Xu, MD Feng Bi, MD Sanjun Cai, MD Chengwei Tang, MD Yulong He, MD Jie Zhong, MD Yupei Zhao, MD |
| author_facet | Lin Cong, MD Wenming Wu, MD Wenhui Lou, MD Jinwan Wang, MD Feng Gu, MD Jiaming Qian, MD Jianming Xu, MD Feng Bi, MD Sanjun Cai, MD Chengwei Tang, MD Yulong He, MD Jie Zhong, MD Yupei Zhao, MD |
| author_sort | Lin Cong, MD |
| collection | DOAJ |
| description | Abstract. Objectives:. The aim of this multicenter, prospective, registry study was to summarize the epidemiology of Chinese patients with locally advanced and end-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as the diagnostic methods and treatment strategies used for these patients.
Methods:. GEP-NET patients from 11 departments of 8 hospitals in China were prospectively enrolled for a pre-defined period (June 30, 2011 to May 29, 2012). The patients’ demographic, pathological, and treatment data were recorded, analyzed, and released on June 29, 2015.
Results:. Seventy-nine eligible patients were enrolled, and most of these patients were classified according to the World Health Organization 2010 classifications. The most common primary tumor site was the pancreas. The liver was the most common site of metastases, followed by the lymph nodes. The majority of the patients underwent surgical interventions. Patients also received local treatment, medication, or chemotherapy.
Conclusion:. The pancreas was the most common primary tumor site of locally advanced and end-stage GEP-NETs. Surgical interventions are currently the most common treatment strategy. |
| first_indexed | 2024-12-24T03:52:17Z |
| format | Article |
| id | doaj.art-cec9d66413ea4fff9c853600745a8e31 |
| institution | Directory Open Access Journal |
| issn | 2096-5664 2577-3577 |
| language | English |
| last_indexed | 2024-12-24T03:52:17Z |
| publishDate | 2018-12-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Journal of Pancreatology |
| spelling | doaj.art-cec9d66413ea4fff9c853600745a8e312022-12-21T17:16:34ZengWolters Kluwer Health/LWWJournal of Pancreatology2096-56642577-35772018-12-0111353810.1097/JP9.0000000000000005201812000-00006Gastroenteropancreatic neuroendocrine tumor registry study in ChinaLin Cong, MDWenming Wu, MDWenhui Lou, MDJinwan Wang, MDFeng Gu, MDJiaming Qian, MDJianming Xu, MDFeng Bi, MDSanjun Cai, MDChengwei Tang, MDYulong He, MDJie Zhong, MDYupei Zhao, MDAbstract. Objectives:. The aim of this multicenter, prospective, registry study was to summarize the epidemiology of Chinese patients with locally advanced and end-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as the diagnostic methods and treatment strategies used for these patients. Methods:. GEP-NET patients from 11 departments of 8 hospitals in China were prospectively enrolled for a pre-defined period (June 30, 2011 to May 29, 2012). The patients’ demographic, pathological, and treatment data were recorded, analyzed, and released on June 29, 2015. Results:. Seventy-nine eligible patients were enrolled, and most of these patients were classified according to the World Health Organization 2010 classifications. The most common primary tumor site was the pancreas. The liver was the most common site of metastases, followed by the lymph nodes. The majority of the patients underwent surgical interventions. Patients also received local treatment, medication, or chemotherapy. Conclusion:. The pancreas was the most common primary tumor site of locally advanced and end-stage GEP-NETs. Surgical interventions are currently the most common treatment strategy.http://journals.lww.com/10.1097/JP9.0000000000000005 |
| spellingShingle | Lin Cong, MD Wenming Wu, MD Wenhui Lou, MD Jinwan Wang, MD Feng Gu, MD Jiaming Qian, MD Jianming Xu, MD Feng Bi, MD Sanjun Cai, MD Chengwei Tang, MD Yulong He, MD Jie Zhong, MD Yupei Zhao, MD Gastroenteropancreatic neuroendocrine tumor registry study in China Journal of Pancreatology |
| title | Gastroenteropancreatic neuroendocrine tumor registry study in China |
| title_full | Gastroenteropancreatic neuroendocrine tumor registry study in China |
| title_fullStr | Gastroenteropancreatic neuroendocrine tumor registry study in China |
| title_full_unstemmed | Gastroenteropancreatic neuroendocrine tumor registry study in China |
| title_short | Gastroenteropancreatic neuroendocrine tumor registry study in China |
| title_sort | gastroenteropancreatic neuroendocrine tumor registry study in china |
| url | http://journals.lww.com/10.1097/JP9.0000000000000005 |
| work_keys_str_mv | AT lincongmd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT wenmingwumd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT wenhuiloumd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT jinwanwangmd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT fenggumd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT jiamingqianmd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT jianmingxumd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT fengbimd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT sanjuncaimd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT chengweitangmd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT yulonghemd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT jiezhongmd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina AT yupeizhaomd gastroenteropancreaticneuroendocrinetumorregistrystudyinchina |